Search Results - "A M Nadzan"

Refine Results
  1. 1

    Sensitization of diabetic and obese mice to insulin by retinoid X receptor agonists by Mukherjee, Ranjan, Davies, Peter J. A, Crombie, Diane L, Bischoff, Eric D, Cesario, Rosemary M, Jow, Lily, Hamann, Lawrence G, Boehm, Marcus F, Mondon, Carl E, Nadzan, Alex M, Paterniti, James R, Heyman, Richard A

    Published in Nature (London) (27-03-1997)
    “…Retinoic acid receptors (RAR), thyroid hormone receptors (TR), peroxisome proliferator activated receptors (PPARs) and the orphan receptor, LXR, bind…”
    Get full text
    Journal Article
  2. 2

    Activation of specific RXR heterodimers by an antagonist of RXR homodimers by Lala, Deepak S, Mukherjee, Ranjan, Schulman, Ira G, Koch, Stacie S. Canan, Dardashti, Laura J, Nadzan, Alex M, Croston, Glenn E, Evans, Ronald M, Heyman, Richard A

    Published in Nature (London) (03-10-1996)
    “…Retinoid X receptor (RXR) plays a central role in the regulation of many intracellular receptor signalling pathways and can mediate ligand-dependent…”
    Get full text
    Journal Article
  3. 3

    Design and Synthesis of Potent Retinoid X Receptor Selective Ligands That Induce Apoptosis in Leukemia Cells by Boehm, Marcus F, Zhang, Lin, Zhi, Lin, McClurg, Michael R, Berger, Elain, Wagoner, Murriel, Mais, Dale E, Suto, Carla M, Davies, Peter J. A, Heyman, Richard A, Nadzan, Alex M

    Published in Journal of medicinal chemistry (01-08-1995)
    “…Structural modifications of the retinoid X receptor (RXR) selective compound 4-[1-(3,5,5,8,8-pentamethyl-5,6,7,8-tetrahydro-2- naphthyl)ethenyl]benzoic acid…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Synthesis of Retinoid X Receptor-Specific Ligands That Are Potent Inducers of Adipogenesis in 3T3-L1 Cells by Canan Koch, Stacie S, Dardashti, Laura J, Cesario, Rosemary M, Croston, Glenn E, Boehm, Marcus F, Heyman, Richard A, Nadzan, Alex M

    Published in Journal of medicinal chemistry (25-02-1999)
    “…A novel series of oxime ligands has been synthesized that displays potent, specific activation of the retinoid X receptors (RXRs). The oximes of 3-substituted…”
    Get full text
    Journal Article
  6. 6

    Intracellular receptors and signal transducers and activators of transcription superfamilies : novel targets for small-molecule drug discovery by ROSEN, J, DAY, A, JONES, T. K, JONES, E. T. T, NADZAN, A. M, STEIN, R. B

    Published in Journal of medicinal chemistry (08-12-1995)
    “…The proliferation and differentiation of mammalian cells is modulated by a number of specific signal molecules that regulate gene expression. Among these…”
    Get full text
    Journal Article
  7. 7

    A novel retinoic acid receptor-selective retinoid, ALRT1550, has potent antitumor activity against human oral squamous carcinoma xenografts in nude mice by SHALINSKY, D. R, BISCHOFF, E. D, LAMPH, W. W, ZHANG, L, BOEHM, M. F, DAVIES, P. J. A, NADZAN, A. M, HEYMAN, R. A

    Published in Cancer research (Chicago, Ill.) (1997)
    “…We have identified a novel retinoid, ALRT1550, that potently and selectively activates retinoic acid receptors (RARs). ALRT1550 binds RARs with Kd values of…”
    Get full text
    Journal Article
  8. 8

    Effects of selective CCK receptor agonists on food intake after central or peripheral administration in rats by Asin, K E, Gore, Jr, P A, Bednarz, L, Holladay, M, Nadzan, A M

    Published in Brain research (31-01-1992)
    “…In this paper report the effects of peripheral (intraperitoneal, i.p.) and central (intracerebroventricular, i.c.v.) injection of selective cholecystokinin…”
    Get more information
    Journal Article
  9. 9

    A-71623, a selective CCK-A receptor agonist, suppresses food intake in the mouse, dog, and monkey by Asin, K E, Bednarz, L, Nikkel, A L, Gore, Jr, P A, Nadzan, A M

    Published in Pharmacology, biochemistry and behavior (01-08-1992)
    “…The anorectic actions of cholecystokinin (CCK)-8 and of a selective CCK-A agonist, A-71623, were examined in CD1 mice, beagle dogs, and cynomolgus monkeys…”
    Get more information
    Journal Article
  10. 10

    Discovery of Novel Retinoic Acid Receptor Agonists Having Potent Antiproliferative Activity in Cervical Cancer Cells by Zhang, Lin, Nadzan, Alex M, Heyman, Richard A, Love, Deborah L, Mais, Dale E, Croston, Glenn, Lamph, William W, Boehm, Marcus F

    Published in Journal of medicinal chemistry (05-07-1996)
    “…Retinoic acid receptor (RAR) active retinoids have proven therapeutically useful for treating certain cancers and dermatological diseases. Herein, we describe…”
    Get full text
    Journal Article
  11. 11

    Behavioral effects of A71623, a highly selective CCK-A agonist tetrapeptide by Asin, K E, Bednarz, L, Nikkel, A L, Gore, Jr, P A, Montana, W E, Cullen, M J, Shiosaki, K, Craig, R, Nadzan, A M

    Published in The American journal of physiology (01-07-1992)
    “…We studied the behavioral effects of a novel cholecystokinin tetrapeptide (CCK-4) analogue, A71623, with full agonist activity and high affinity and…”
    Get full text
    Journal Article
  12. 12

    Intraventricular CCK-8 reduces single meal size in the baboon by interaction with type-A CCK receptors by Figlewicz, D P, Nadzan, A M, Sipols, A J, Green, P K, Liddle, R A, Porte, Jr, D, Woods, S C

    Published in The American journal of physiology (01-10-1992)
    “…Intraventricular cholecystokinin COOH-terminal octapeptide (CCK-8) decreases meal size in the meal-trained baboon. In the present study, we tested whether this…”
    Get full text
    Journal Article
  13. 13

    Characterization of two novel cholecystokinin tetrapeptide (30-33) analogues, A-71623 and A-70874, that exhibit high potency and selectivity for cholecystokinin-A receptors by Lin, C W, Shiosaki, K, Miller, T R, Witte, D G, Bianchi, B R, Wolfram, C A, Kopecka, H, Craig, R, Wagenaar, F, Nadzan, A M

    Published in Molecular pharmacology (01-03-1991)
    “…Based on their relative affinities for cholecystokinin octapeptide (26-33) (CCK-8), cholecystokinin tetrapeptide (30-33) (CCK-4), desulfated CCK-8, and…”
    Get more information
    Journal Article
  14. 14

    Structural identification of the major DNA adduct formed by aflatoxin B1 in vitro by J M Essigmann, R G Croy, A M Nadzan, W F Busby, Jr, V N Reinhold, G Büchi, G N Wogan

    “…The covalent binding of the hepatocarcinogen aflatoxin B1 by rat liver microsomes to calf thymus DNA resulted in a binding level equal to one aflatoxin residue…”
    Get full text
    Journal Article
  15. 15

    Distinct requirements for activation at CCK-A and CCK-B/gastrin receptors: studies with a C-terminal hydrazide analogue of cholecystokinin tetrapeptide (30-33) by Lin, C W, Holladay, M W, Barrett, R W, Wolfram, C A, Miller, T R, Witte, D, Kerwin, Jr, J F, Wagenaar, F, Nadzan, A M

    Published in Molecular pharmacology (01-12-1989)
    “…We describe here the properties of tert-butyloxycarbonyl-Trp-Leu-Asp-Phe-NHNH2 (A-57696), a C-terminal hydrazide analogue of tert-butyloxycarbonyl-CCK4…”
    Get more information
    Journal Article
  16. 16

    Cholecystokinin receptors: relationships among phosphoinositide breakdown, amylase release and receptor affinity in pancreas by Lin, C W, Bianchi, B R, Grant, D, Miller, T, Danaher, E A, Tufano, M D, Kopecka, H, Nadzan, A M

    “…The gut hormone cholecystokinin (CCK) octapeptide stimulates the release of amylase from exocrine pancreas, a process believed to be the result of the…”
    Get more information
    Journal Article
  17. 17

    Boc-CCK-4 derivatives containing side-chain ureas as potent and selective CCK-A receptor agonists by Shiosaki, Kazumi, Lin, Chun Wel, Kopecka, Hana, Tufano, Michael D, Bianchi, Bruce R, Miller, Thomas R, Witte, David G, Nadzan, Alex M

    Published in Journal of medicinal chemistry (01-09-1991)
    “…Novel Boc-CCK-4 derivatives were communicated recently as having high potency and selectivity for the CCK-A receptor (Shiosaki et al. J. Med. Chem. 1990, 33,…”
    Get full text
    Journal Article
  18. 18

    A71378: a CCK agonist with high potency and selectivity for CCK-A receptors by Lin, C W, Holladay, M W, Witte, D G, Miller, T R, Wolfram, C A, Bianchi, B R, Bennett, M J, Nadzan, A M

    Published in The American journal of physiology (01-04-1990)
    “…Receptors for the brain and gut peptide cholecystokinin (CCK) have been classified into two classes, CCK-A and CCK-B. To date, peptide analogues with…”
    Get full text
    Journal Article
  19. 19
  20. 20

    Centrally administered CCK-8 suppresses activity in mice by a "peripheral-type" CCK receptor by Britton, D R, Yahiro, L, Cullen, M J, Kerwin, Jr, J F, Kopecka, H, Nadzan, A M

    Published in Pharmacology, biochemistry and behavior (01-12-1989)
    “…Cholecystokinin octapeptide (CCK-8) administered either systemically (IP) or centrally (ICV) suppresses several types of behavior in mice including exploratory…”
    Get more information
    Journal Article